ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >protein tyrosine kinase >Alectinib

Alectinib

Alectinib Structure
CAS No.
1256580-46-7
Chemical Name:
Alectinib
Synonyms
Alecensa;Alecitinib;Alectinib (CH5424802);AF-802;CS-217;canna*;RG-7853;alectinb;Aletinib;Alectinib
CBNumber:
CB62534680
Molecular Formula:
C30H34N4O2
Molecular Weight:
482.62
MOL File:
1256580-46-7.mol
Modify Date:
2024/5/20 14:06:47

Alectinib Properties

Melting point 274-276°C
Boiling point 722.5±60.0 °C(Predicted)
Density 1.28
storage temp. -20°
solubility Soluble in DMSO (up to 5 mg/ml with warming).
form solid
pka 13.70±0.40(Predicted)
color White
Stability Stable for 1 year from date of purchase as supplied. Solutions are not stable and should be prepared fresh daily.

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H361-H341-H373
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P201-P202-P281-P308+P313-P405-P501-P260-P314-P501
HS Code  2934999090

Alectinib Chemical Properties,Uses,Production

Description

Alectinib is another selective ALK inhibitor that is able to overcome resistance mutations from prior crizotinib exposure [38].

Chemical Properties

White to Off-White Solid

Indications

Alectinib (Alecensa(R), Roche) was approved first in Japan in 2014 and then by US FDA in 2015 as a second-generation ALK inhibitor for NSCLC treatment on patients who have progressed or do not tolerate crizotinib. Developed through a structure-based drug design approach, alectinib is a benzocarbazolone derivative that has shown potent inhibitory activity against ALK (IC50 value of 1.9 nM) and gatekeeper mutant L1196M ALK (IC50 value of 1.6 nM). Alectinib is effective with crizotinib-resistant ALK mutations on L1196M, F1174L, R1275Q, and C1156Y. In addition, an array of small-molecule inhibitors are currently being evaluated by several clinical trials for ALK-driven tumors.

Definition

ChEBI: An organic heterotetracyclic compound that is 6,6-dimethyl-5,6-dihydro-11H-benzo[b]carbazol-11-one carrying additional cyano, 4-(morpholin-4-yl)piperidin-1-yl and ethyl substituents at positions 3, 8 and 9 respectively. Used (as the hydr chloride salt) for the treatment of patients with anaplastic lymphoma kinase-positive, metastatic non-small cell lung cancer.

brand name

Alecensa?

General Description

Class: receptor tyrosine kinase; Treatment: NSCLC; Oral bioavailability = 37%; Elimination half-life = 33 h; Protein binding = >99%

target

Primary targets: ALK (IC50 = 1.9 nM)/RET (IC50 = 4.8 nM)

Global( 307)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
AVD pharmaceuticals Pvt Ltd +919860835260 Pune, India 102 58 Inquiry
Dr. Reddy's Laboratories Ltd +91-4049002900 +91-4049002900 Hyderabad, India 165 58 Inquiry
Aspen Biopharma Labs Pvt Ltd +91-9248058660 +91-9248058662 Telangana, India 234 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
Hangzhou FandaChem Co.,Ltd. 008657128800458; +8615858145714 China 9337 55 Inquiry

Related articles

  • What is Alectinib?
  • Alectinib (trade name Alecensa) is a new type of highly selective ALK-TKI, which was approved by the US FDA on December 11, 20....
  • Dec 26,2019

Alectinib Spectrum

AF-802 CH-5424802/RG-7853 Alectinib AF-802,RG-7853 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile Alectinib (CH5424802) CH5424802-alectinib 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile CH5424802 CH5424802, Alectinib, AF802 9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile 9-ETHYL-6,6-DIMETHYL-8-(4-MORPHOLINOPIPERIDIN-1-YL)-11-OXO-6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE CH5424802 AF 802; AF-802; AF802; CH5424802; CH5424802; CH 5424802; RO5424802; RO 5424802; RO5424802, ALECTINIB; BRAND NAME: ALECENSA brand name: Alecensa RO 5424802 RO5424802 RO5424802, Alectinib RG-7853 AF-802; CH 5424802; CH-5424802; AF802; AF 802 alectinb CS-217 Alectinib free base 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile 5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo- 9-Ethyl-6,6-dimethyl-8-(4-morpholino-1-piperidyl)-11-oxo-5H-benzobcarbazole-3-carbonitrile Alectinib USP/EP/BP 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile Alectinib Alectinib (AF-802, CH-5424802, RO-5424802, Alecensa) canna* Alectinib (CH5424802) Alecensa Alecitinib Elle, on behalf of, Alectinib free base Alectinib base Aletinib 1256580-46-7 Anti-cancer&immunity Inhibitors API API